Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NeuroSense Therapeutics Ltd. - Ordinary Shares
(NQ:
NRSN
)
0.7039
-0.0061 (-0.86%)
Streaming Delayed Price
Updated: 11:02 AM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about NeuroSense Therapeutics Ltd. - Ordinary Shares
NeuroSense Inches Closer to Pharma Partnership as Canadian Regulatory Progress Turns Heads
June 26, 2025
NeuroSense Inches Closer to Pharma Partnership as Canadian Regulatory Progress Turns Heads
Via
News Direct
Topics
Regulatory Compliance
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
March 20, 2025
From
Market News Alerts
Via
Business Wire
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
March 17, 2025
From
PESG Research
Via
Business Wire
Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC
October 19, 2023
Via
ACCESSWIRE
NeuroSense Therapeutics (NASDAQ: NRSN) Shares Positive Final Results From Alzheimer’s Disease Biomarker Study
January 19, 2023
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN) is a clinical-stage biotechnology company, which is focused on the research and development of treatments
Via
Spotlight Growth
Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027
June 28, 2022
Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...
Via
FinancialNewsMedia
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
